Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix...
-
Upload
homer-kelley-carpenter -
Category
Documents
-
view
213 -
download
0
Transcript of Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix...
![Page 1: Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.](https://reader033.fdocuments.us/reader033/viewer/2022051621/5697bf701a28abf838c7d61b/html5/thumbnails/1.jpg)
Ila Saunders, PharmD, BCOPResearch Interests
• Impact of clinical pharmacy services in a matrix cancer center
• Impact of a “Transitions of Care” clinical pharmacy program in an allogeneic stem cell transplant (SCT) population
• Adherence to oral chemotherapy in the thoracic oncology population—how does it affect outcome?
• Use of temsirolimus in the treatment of chronic graft-versus-host-disease
![Page 2: Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.](https://reader033.fdocuments.us/reader033/viewer/2022051621/5697bf701a28abf838c7d61b/html5/thumbnails/2.jpg)
Core Expertise
• Blood & marrow transplantation• Immunosuppression and therapeutic drug monitoring• Post-allogeneic and autologous SCT medication management • Management of infectious complications s/p allogeneic SCT• Management of acute and chronic graft-versus-host disease• Vaccinations/survivorship
• Thoracic oncology • Chemotherapy teaching/education • Adherence evaluation/monitoring • Medication reconciliation
![Page 3: Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.](https://reader033.fdocuments.us/reader033/viewer/2022051621/5697bf701a28abf838c7d61b/html5/thumbnails/3.jpg)
Proposed Collaborations with SSPPS Faculty
• Development of strategic plan for clinical pharmacy at Moores Cancer Center (with Chuck Daniels)
• Address clinical pharmacy service growth and impact